In a study involving 36 APS patients, Oku et al. (2009) observed lower levels of C3 and C4, alongside increased C3a and C4a levels, suggesting enhanced consumption of the former molecules [45]. The gene discussed is C4A; the disease is autoimmune polyendocrinopathy.